Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 3Phase 2 1

Status

Completed 7

Sponsor Class

OTHER 3NIH 2NETWORK 1INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7Genitourinary 3Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 7Osteoporosis 1Cardiovascular Diseases 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Raloxifene Hydrochloride × Breast × Clear all
NCT00723398 2018-11-01

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Milton S. Hershey Medical Center

Phase NA Completed
266 enrolled 20 charts
Breast

Breast Neoplasms

NCT00687102 2018-09-12

Co-STAR

Wake Forest University Health Sciences

Phase 3 Completed
1,498 enrolled 13 charts
Breast

Breast Neoplasms

NCT00003906 2015-10-06

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

NSABP Foundation Inc

Phase 3 Completed
19,747 enrolled
Breast

Breast Neoplasms

NCT00031850 2013-06-26

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
150 enrolled
Breast

Breast Neoplasms

NCT00019500 2013-06-20

Raloxifene in Preventing Breast Cancer in Premenopausal Women

National Cancer Institute (NCI)

Phase 2 Completed
Breast

Breast Neoplasms

NCT00031811 2012-05-28

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

OHSU Knight Cancer Institute

Phase NA Completed
80 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00190593 2007-01-26

Raloxifene Use for The Heart

Eli Lilly and Company

Phase 3 Completed
10,000 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡